  The following review is being published by the American Society for Metabolic and Bariatric Surgery in response to numerous inquiries made to the Society by patients , physicians , society members , hospitals , and others regarding one-anastomosis gastric bypass as a primary treatment for obesity or metabolic disease. The review is based on current clinical knowledge , expert opinion , and published peer-reviewed scientific evidence available at this time. The review is not intended as , and should not be construed as , stating or establishing a local , regional , or national standard of care.